The Ministry of Health of Guyana, with support from the Pan American Health Organization (PAHO) and the European Union (EU), launched a regional workshop in Georgetown from 2–4 February 2026 to strengthen regulatory systems for medicines and health technologies across the Caribbean. Funded by the EU and implemented by Lithuania’s Central Project Management Agency, the three-day event brought together regulatory experts from the Caribbean and Europe to advance harmonization, improve access to quality-assured medicines, and foster collaboration among national and regional regulatory authorities. The workshop focused on building resilient regulatory environments to ensure public trust and safer healthcare systems.
The initiative is part of the EU’s Global Gateway strategy and long-standing cooperation with the Caribbean Public Health Agency (CARPHA) and national ministries of health. Ambassador Luca Pierantoni highlighted that regional integration relies on trust and collaboration, noting the EU’s commitment to supporting sector development in Guyana and the wider Caribbean. PAHO/WHO emphasized that strong regulatory systems are essential for protecting public health, ensuring that medicines, vaccines, and medical devices meet safety, efficacy, and quality standards.
Minister of Health Hon. Dr. Frank Anthony reflected on lessons from the COVID-19 pandemic, noting the vulnerabilities in global supply chains and the importance of regional preparedness. The EU’s PharmaNext programme will play a key role in strengthening pharmaceutical value chains and regulatory capacity across the Caribbean, with Guyana positioned as a strategic partner.
Guyana has invested in a modern pharmaceutical ecosystem through initiatives such as a state-of-the-art Food and Drug laboratory, digitalization of regulatory processes, expanded clinical research capacity, and the development of a Life Sciences Park. PAHO/WHO and the EU reaffirmed their commitment to ongoing technical collaboration and engagement with partners to advance shared priorities in regulatory strengthening and public health outcomes for the region.
